Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$5.03 - $11.63 $1.82 Million - $4.21 Million
-361,821 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$9.29 - $14.27 $249,167 - $382,735
26,821 Added 8.01%
361,821 $3.38 Million
Q1 2021

May 14, 2021

BUY
$11.89 - $35.55 $3.98 Million - $11.9 Million
335,000 New
335,000 $4.66 Million

About Oncorus, Inc.


  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.